Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Novo Nordisk strikes second licensing deal since frosty capital-markets day

Novo Nordisk on Tuesday struck its second licensing deal since receiving a poor reception from investors after presenting its long-term strategy.

Novo Nordisk strikes second licensing deal since frosty capital-markets day

We haven't written up this one. MarketWatch Top has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at marketwatch.com →

More in Finance & Markets

More from Tuesday 29 September →